Concepedia

Paul Ardayfio

PA

22

Publications

4.7K

Citations

17

H-Index

2000

Active since

Affiliations

Eli Lilly (United States)(Current)

Harvard University

Butler Hospital

McLean Hospital

Brown University

Paul Ardayfio is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and neuroscience.

Top concepts

Publications per year

2000–2025

22

Publications

22

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.2K citations · Full text

Donanemab in Early Alzheimer’s Disease

Mark A. Mintun, Albert Lo, Cynthia Evans et al. · New England Journal of Medicine · 2021 · 1.5K citations · Full text

3,4-Dihydroxyphenylalanine Reverses the Motor Deficits in Pitx3-Deficient<i>Aphakia</i>Mice: Behavioral Characterization of a Novel Genetic Model of Parkinson's Disease

Dong‐Youn Hwang, Sheila M. Fleming, Paul Ardayfio et al. · Journal of Neuroscience · 2005 · 172 citations · Full text

Anxiogenic-like effect of chronic corticosterone in the light-dark emergence task in mice.

Paul Ardayfio, Kwang‐Soo Kim · Behavioral Neuroscience · 2006 · 121 citations

, , +24

Donanemab (LY3002813) dose‐escalation study in Alzheimer's disease

Stephen L. Lowe, Brian A. Willis, Anne Hawdon et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2021 · 114 citations · Full text

Rows per page

1–5 of 22